|
Xencor’s CEO Discusses Q4 2013 Results – Earnings Call Transcript
Seeking Alpha So that’s a potential significant differentiator for safety purposes from cytotoxic B-cell antibodies that are currently used in autoimmune disease such as rituximab. Now, our partner Amgen has an option to acquire the exclusive worldwide license to … |
5 hospitals off CGHS's empanelment list – Times of India
Economic Times |
5 hospitals off CGHS’s empanelment list
Times of India The hospitals include Fortis Escort Heart Institute (Faridabad), Fortis (Jaipur), Delhi Heart and Lung Institute and Bangalore’s M S Ramaiah Hospital. The estimated number of beneficiaries of the health scheme is nearly one crore with 407 private … 24 pvt hospitals get showcause noticesBusiness Standard |
Petition started to challenge blood donation rules for gay men – PinkNews.co.uk
Petition started to challenge blood donation rules for gay menPinkNews.co.ukA petition has been started to challenge blood donation rules for men who have sex with men in the UK. The petition was started by 2nd year History Student at the University of…
Pre-Transplant Vidaza May Improve Stem Cell Transplant Outcomes In Higher … – The MDS Beacon
Pre-Transplant Vidaza May Improve Stem Cell Transplant Outcomes In Higher …The MDS BeaconResults of a small prospective study conducted at the Lee Moffitt Cancer Center suggest that pre-transplant treatment with Vidaza may improve the outcomes of don…
Marit Cup honours memory of young organ donor – Globalnews.ca
Globalnews.caMarit Cup honours memory of young organ donorGlobalnews.caOrgan donation is a critical issue for Alberta, which used to be the leading province in organ donation, but has fallen to last in the last decade. There are now only 10 donations a…
'Perfect Strangers' film on organ donation to show at Vermilionville – KATC Lafayette News
|
‘Perfect Strangers’ film on organ donation to show at Vermilionville
KATC Lafayette News Intimate scenes with Ellie, Kathy, and their families reveal the complicated physical and emotional terrain of organ donation. ABOUT THE FILMMAKER. Jan Krawitz has been independently producing documentary films for 35 years. Her work has been |
Obinutuzumab Beats Rituximab in CLL – Medscape
Medscape |
Obinutuzumab Beats Rituximab in CLL
Medscape The new anti-CD20 antibody obinutuzumab (Gazya) performed better than the older product rituximab (Rituxan) when both were added to chemotherapy in previously untreated patients with chronic lymphocytic leukemia (CLL) and comorbidities. North Shore-LIJ Cancer Institute doctors’ editorial publishedEurekAlert (press release) |
North Shore-LIJ Cancer Institute doctors' editorial published – EurekAlert (press release)
|
North Shore-LIJ Cancer Institute doctors’ editorial published
EurekAlert (press release) Researchers compared the benefits of obinutuzumab with that of another antibody rituximab, which also attacks CD20. Both drugs were combined with the chemotherapy drug chlorambucil. They found that subjects receiving obinutuzumab-chlorambucil had … |
The long-awaited call that changed my life – The Border Mail
|
The long-awaited call that changed my life
The Border Mail With that, Ms Coulthard was whisked to Melbourne for the transplant surgery that would literally change her whole life. That was five years ago — up until that day, the Wodonga woman needed oxygen to get through each day living with the rare genetic … |
Introduction: Multidisciplinary Frontline Treatment of mRCC – OncLive
Introduction: Multidisciplinary Frontline Treatment of mRCCOncLiveMost patients with untreated metastatic renal cell carcinoma (mRCC) have already undergone nephrectomy, Rini notes. At this point, the standard frontline treatment is usually the VEGF in…